<乌鸦传媒>Wyeth Settles Rapamune Marketing Charge WASHINGTON, D.C. -- Pfizer's Wyeth Pharmaceuticals unit will pay $490.9 million to resolve state and federal allegations that it marketed rapamycin (sirolimus, Rapamune) for unapproved indications. Jul 31, 2013
<乌鸦传媒>Recall: Device Sucks Life From Patient A suction system for collecting surgical waste apparently killed one patient and seriously injured another, prompting its maker to recall it and several related devices, the FDA said. Oct 05, 2012
<乌鸦传媒>The Top 10 Medical Advances of the Decade From genome to hormones, doctors pick the top medical advances of the decade. Dec 17, 2009